Keyphrases
Postmenopausal Women
100%
Prospective Cohort Study
100%
Growth Factors
100%
Breast Cancer Prognosis
100%
Binding Protein
100%
Denmark
100%
Insulin-like
100%
Hazard Ratio
36%
Insulin-like Growth Factor 2 (IGF2)
36%
Confidence Interval
36%
Breast Cancer Mortality
36%
Mortality Hazard
27%
Breast Cancer
27%
Serum Levels
27%
Estrogen Receptor Status
27%
Effect Modification
18%
Cox Proportional Hazards Model
9%
Etiology
9%
All-cause Mortality
9%
Follow-up Time
9%
Danish Registry
9%
Sensitivity Analysis
9%
Recurrence Hazard
9%
Low Risk
9%
Serum Samples
9%
Circulating Levels
9%
Recurrence Risk
9%
Breast Cancer Risk
9%
Medicine and Dentistry
Prospective Cohort Study
100%
Somatomedin
100%
Postmenopause
100%
Cancer Prognosis
100%
Breast Cancer
100%
Protein Binding
64%
Somatomedin B
23%
Synapsin II
23%
Hazard Ratio
23%
Estrogen Receptor
17%
Somatomedin C
17%
Recurrent Disease
11%
All Cause Mortality
5%
Cancer Risk
5%
Gene Linkage
5%
Proportional Hazards Model
5%
Diet and Cancer
5%
Diagnosis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Cohort Study
100%
Breast Cancer
100%
Cancer Prognosis
100%
Somatomedin
100%
Binding Protein
64%
Somatomedin B
23%
Synapsin II
23%
Estrogen Receptor
17%
Somatomedin C
17%
Recurrent Disease
11%
All Cause Mortality
5%
Malignant Neoplasm
5%
Biochemistry, Genetics and Molecular Biology
Binding Protein
100%
Prospective Cohort Study
100%
Insulin-Like Growth Factor
100%
Postmenopause
100%
Insulin-Like Growth Factor 2
36%
Insulin-Like Growth Factor 1
27%
Estrogen Receptor
27%
Blood Level
27%
Gene Linkage
9%
All Cause Mortality
9%
Immunology and Microbiology
Postmenopause
100%
Protein Binding
100%
Somatomedin
100%
Somatomedin B
36%
Somatomedin C
27%
Blood Level
27%
All Cause Mortality
9%
Psychology
Breast Cancer
100%
Hazard Ratio
23%
Proportional Hazards Regression Model
5%